NEWS & EVENTS
The latest from Touchlight
Upcoming Events
From Plasmids to Cell-free DNA using Megabulb DNA: How Touchlight and ElevateBio are Enabling Safer and More Effective Cell and Gene Therapies
20 October 2025 | Webinar ...
Touchlight Introduces mbDNA™: A “best-in-class” cell-free circular ssDNA platform enabling superior gene editing
Touchlight Introduces mbDNA™: A “best-in-class" circular single stranded DNA (ssDNA) platform enabling superior gene editing Published: 30 July 2025Touchlight, a ...
Touchlight Wins ISPE Facility of the Year Award for Innovation, Recognised for Revolutionary dbDNA™ Manufacturing at Morelands Facility
Touchlight Wins ISPE Facility of the Year Award for Innovation, Recognised for Revolutionary dbDNA™ Manufacturing at Morelands Facility Published: 12 ...
Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms
Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms Published: 27 January 2025 ...
Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health
Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health Published: 16 January 2025 ...
Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA
Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA Published: 14 January 2025 Touchlight’s dbDNA technology is the first ...
Touchlight to supply GMP dbDNA to support University of Nottingham’s clinical study for a next-generation vaccine for Zika virus
Touchlight to supply GMP dbDNA to support University of Nottingham’s clinical study for a next-generation vaccine for Zika virus Published: ...
Touchlight and GSK sign license agreement for use of enzymatic dbDNA production technology for mRNA manufacturing
Touchlight and GSK sign license agreement for use of enzymatic dbDNA production technology for mRNA manufacturing Published: 23 July 2024 ...
Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response
Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response Published: 2 July 2024 Touchlight to participate ...
Touchlight Genetics and the National Physical Laboratory (NPL) awarded grant to develop novel gene-length single-stranded genome editing template.
Touchlight Genetics and the National Physical Laboratory (NPL) awarded grant to develop novel gene-length single-stranded genome editing template. Published: 9 ...
Touchlight awarded grant extension to further develop DNA-enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory
Touchlight awarded grant extension to further develop DNA-enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & ...
University of Liverpool to use Touchlight’s rapid enzymatic dbDNA in fully personalised neoantigen cancer vaccine clinical study
University of Liverpool to use Touchlight’s rapid enzymatic dbDNA in fully personalised neoantigen cancer vaccine clinical study Published: 4 April ...
Touchlight awarded tender to supply enzymatic dbDNA to CPI’s RNA Centre of Excellence
Touchlight awarded tender to supply enzymatic dbDNA to CPI’s RNA Centre of Excellence Published: 28 March 2024 Touchlight, an innovation-driven ...
Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study
Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study Published: 21 November 2023 Based ...
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA Published: 24 July 2023 Curia collaborates with Touchlight to expand ...
20Med Therapeutics and Touchlight to collaborate on novel vaccine delivery platform project
20Med Therapeutics and Touchlight to collaborate on novel vaccine delivery platform project Published: 18 April 2023 Curia collaborates with Touchlight ...
Touchlight secures government grant to support its £14m investment in scale-up DNA manufacturing
Touchlight secures government grant to support its £14m investment in scale-up DNA manufacturing Published: 29 March 2023 headline Hampton, UK, ...
Touchlight announces first FDA clearance of an IND utilising doggybone DNA
Touchlight announces first FDA clearance of an IND utilising doggybone DNA Published: 28 February 2023 Enzymatic doggybone DNA material used ...
Touchlight signs license agreement with Voyager for use of Touchlight’s DNA technology in Voyager’s capsid discovery platform
Touchlight signs license agreement with Voyager for use of Touchlight’s DNA technology in Voyager’s capsid discovery platform Published: 15 November ...
Lonza and Touchlight collaborate on end-to-end mRNA offering
Lonza and Touchlight collaborate on end-to-end mRNA offering Published: 6 September 2022 Collaboration expands Lonza’s end-to-end offering for mRNA manufacturing ...
Touchlight signs patent license agreement with Pfizer for the use of dbDNA for the manufacture of mRNA-based vaccines, therapeutics and gene therapies
Touchlight signs patent license agreement with Pfizer for the use of dbDNA for the manufacture of mRNA-based vaccines, therapeutics and ...
AskBio and Touchlight Restructure Joint Venture
AskBio and Touchlight Restructure Joint Venture Published: 8 February 2022 Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned ...
Plasmid DNA Challenges In Advanced Therapy Manufacturing
Plasmid DNA Challenges In Advanced Therapy Manufacturing Published: 24 November 2021 Dr Tommy Duncan Introducing doggybone DNA, a synthetic antibiotic-free ...
Touchlight Ranked Number Four Fastest Growing Technology Company in the UK in the 2021 Deloitte Technology Fast 50
Touchlight Ranked Number Four Fastest Growing Technology Company in the UK in the 2021 Deloitte Technology Fast 50 Published: 22 ...
Touchlight raises £42 million ($58 million) to meet unprecedented global DNA demand
Touchlight raises £42 million ($58 million) to meet unprecedented global DNA demand Published: 11 March 2021 Touchlight raises £42 million ...
Touchlight appoints Karen Fallen as CEO of Touchlight DNA Services
Touchlight appoints Karen Fallen as CEO of Touchlight DNA Services Published: 15 October 2020 Former Lonza President of Biologics Manufacturing ...
Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture
Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture Published: 29 September 2020 Curia collaborates with Touchlight to expand its mRNA ...
